APA (7th ed.) Citation

MJ, L., LR, C., P, Z., S, C., M, F., E, F., . . . S, F. (2026). Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): A double-blind, randomised, placebo-controlled trial. The lancet. HIV, 13(8), e527. https://doi.org/10.1016/S2352-3018(26)00059-7

Chicago Style (17th ed.) Citation

MJ, Lee, et al. "Time to HIV Rebound After Infusion of Long-acting Broadly Neutralising Antibodies 3BNC117-LS and 10-1074-LS and Analytical Treatment Interruption (the RIO Trial): A Double-blind, Randomised, Placebo-controlled Trial." The Lancet. HIV 13, no. 8 (2026): e527. https://doi.org/10.1016/S2352-3018(26)00059-7.

MLA (9th ed.) Citation

MJ, Lee, et al. "Time to HIV Rebound After Infusion of Long-acting Broadly Neutralising Antibodies 3BNC117-LS and 10-1074-LS and Analytical Treatment Interruption (the RIO Trial): A Double-blind, Randomised, Placebo-controlled Trial." The Lancet. HIV, vol. 13, no. 8, 2026, p. e527, https://doi.org/10.1016/S2352-3018(26)00059-7.